XML 87 R74.htm IDEA: XBRL DOCUMENT v3.3.1.900
Stock-based Compensation (Details)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 04, 2015
USD ($)
shares
Dec. 31, 2015
USD ($)
$ / shares
shares
Sep. 30, 2015
$ / shares
shares
Dec. 31, 2015
USD ($)
plan
$ / shares
shares
Dec. 31, 2014
USD ($)
$ / shares
shares
Dec. 31, 2013
USD ($)
$ / shares
shares
May. 22, 2013
shares
Dec. 31, 2003
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Number of compensation plans | plan       2        
Total stock-based compensation expense | $       $ 22,500,000 $ 13,400,000 $ 16,900,000    
Fair value assumptions and methodology [Abstract]                
Expected volatility range of stock, minimum (in hundredths)       34.00% 56.70% 63.00%    
Expected volatility range of stock, maximum (in hundredths)       36.20% 66.50% 72.80%    
Expected life of option, range in years, minimum       3 years 2 years 2 years    
Expected life of option, range in years, maximum       5 years 4 years 3 years    
Risk-free interest rate range, minimum (in hundredths)       0.90% 0.40% 0.30%    
Risk-free interest rate range, maximum (in hundredths)       1.50% 1.40% 0.60%    
Expected dividend yield on stock, minimum (in hundredths)       0.00% 0.60% 0.60%    
Expected dividend yield on stock, maximum (in hundredths)       0.00% 0.70% 0.90%    
Weighted Average Exercise Price                
Total intrinsic value of options exercised | $       $ 71,800,000 $ 6,700,000 $ 17,100,000    
Total unrecognized stock-based compensation expense | $   $ 28,000,000   $ 28,000,000        
Weighted Average Remaining Vesting Period (in years)       2 years 5 months 9 days        
Cash received from exercise of stock options | $       $ 20,400,000 $ 4,300,000 $ 8,700,000    
Treasury Stock                
Shares                
Released (in shares)       (1,300,000) (200,000) (600,000)    
Performance-based Restricted Stock Units                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Total stock-based compensation expense | $       $ 13,700,000 $ 3,500,000 $ 3,000,000    
Revaluation benefit from PRSU Granted | $       $ 0 $ 3,000,000 $ 0    
Shares                
Beginning balance (in shares)     300,000 300,000 300,000      
Granted (in shares)       1,700,000 300,000      
Vested (in shares)       0 0      
Forfeited/Terminated (in shares)       (100,000) (300,000)      
Ending balance (in shares)   1,900,000   1,900,000 300,000 300,000    
Weighted Average Grant Date Fair Value                
Beginning balance (in dollars per share) | $ / shares     $ 53.45 $ 53.45 $ 39.04      
Granted (in dollars per share) | $ / shares       70.43 51.87      
Vested (in dollars per share) | $ / shares       0.00 37.05      
Forfeited/Terminated (in dollars per share) | $ / shares       56.74 39.38      
Ending balance (in dollars per share) | $ / shares   $ 68.17   $ 68.17 $ 53.45 $ 39.04    
Outstanding intrinsic value | $   $ 13,900,000   $ 13,900,000        
Weighted Average Exercise Price                
Total unrecognized stock-based compensation expense | $   10,900,000   $ 10,900,000        
Weighted Average Remaining Vesting Period (in years)       2 years 3 months 15 days        
Performance-based Restricted Stock Units | 2018 if target is not met                
Weighted Average Grant Date Fair Value                
Percentage of target shares to vest       33.33%        
Number of target shares to vest       460,000        
Performance-based Restricted Stock Units | Treasury Stock                
Weighted Average Grant Date Fair Value                
Grant date intrinsic value | $       $ 0 $ 1,400,000 $ 14,900,000    
Performance period (in years)       1 year        
Percentage of stock units released       100.00%   282.00%    
Maximum payout (percent)           300.00%    
Performance-based Restricted Stock Units | Chief Executive Officer | 2018 if target is not met                
Weighted Average Grant Date Fair Value                
Percentage of target shares to vest 33.33%              
Performance-based Restricted Stock Units | December 31, 2017                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Target shares granted     260,000          
Weighted Average Grant Date Fair Value                
Maximum Number of Shares to be Awarded     780,000          
Performance-based Restricted Stock Units | December 31, 2017 if target is met                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Target shares granted     1,390,000          
Weighted Average Grant Date Fair Value                
Maximum Number of Shares to be Awarded     1,390,000          
Performance-based Restricted Stock Units | Three annual installments beginning on September 4, 2016                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Target shares granted     70,000          
Weighted Average Grant Date Fair Value                
Maximum Number of Shares to be Awarded     70,000          
Stock Options                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Total stock-based compensation expense | $       $ 6,600,000 7,000,000 $ 8,300,000    
Weighted Average Exercise Price                
Total unrecognized stock-based compensation expense | $   $ 9,200,000   $ 9,200,000        
Weighted Average Remaining Vesting Period (in years)       2 years 5 months 27 days        
Restricted Stock Units and Deferred Stock Units                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Total stock-based compensation expense | $       $ 2,200,000 $ 2,900,000 $ 5,600,000    
Shares                
Beginning balance (in shares)     100,000 100,000 200,000      
Granted (in shares)       100,000 0      
Vested (in shares)       (100,000) (100,000)      
Forfeited/Terminated (in shares)       0 0      
Ending balance (in shares)   100,000   100,000 100,000 200,000    
Weighted Average Grant Date Fair Value                
Beginning balance (in dollars per share) | $ / shares     $ 50.41 $ 50.41 $ 47.00      
Granted (in dollars per share) | $ / shares       70.44 54.56      
Vested (in dollars per share) | $ / shares       58.73 44.47      
Forfeited/Terminated (in dollars per share) | $ / shares       49.63 46.77      
Ending balance (in dollars per share) | $ / shares   $ 66.41   $ 66.41 $ 50.41 $ 47.00    
Weighted Average Exercise Price                
Aggregate intrinsic value of units outstanding | $   $ 11,900,000   $ 11,900,000        
Aggregate intrinsic value of RSUs and DSUs vested during the period | $       4,000,000        
Total unrecognized stock-based compensation expense | $   $ 7,900,000   $ 7,900,000        
Weighted Average Remaining Vesting Period (in years)       2 years 7 months 2 days        
Unvested Stock Options                
Shares                
Beginning balance (in shares)     500,000 500,000 600,000      
Granted (in shares)       800,000 200,000      
Vested (in shares)       (400,000) (300,000)      
Forfeited (in shares)       (100,000) 0      
Ending balance (in shares)   800,000   800,000 500,000 600,000    
Weighted Average Grant Date Fair Value                
Beginning of period weighted average grant date fair value (dollars per share) | $ / shares     $ 46.23 $ 46.23 $ 42.16      
Granted weighted average grant date fair value (dollars per share) | $ / shares       63.55 52.08      
Vested weighted average grant date fair value (dollars per share) | $ / shares       44.25 42.46      
Forfeited weighted average grant date fair value (dollars per share) | $ / shares       57.12 50.53      
Ending of period weighted average grant date fair value (dollars per share) | $ / shares   $ 62.34   $ 62.34 $ 46.23 $ 42.16    
Long Term Incentive Plan 2013                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Maximum number of common stock shares to be issued (in shares)             5,100,000  
Amended And Restated 2003 Equity Incentive Plan | Stock Options                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Maximum number of common stock shares to be issued (in shares)               11,500,000
Aspirational Plan | Performance-based Restricted Stock Units | Chief Executive Officer                
Shares                
Granted (in shares) 620,000              
Weighted Average Grant Date Fair Value                
Minimum Adjusted EBITDA (more than) | $ $ 650,000,000              
Unrecognized compensation expense | $ $ 44,500,000 $ 56,600,000   $ 56,600,000        
Aspirational Plan | Performance-based Restricted Stock Units | Executive Officer                
Shares                
Granted (in shares)   770,000            
Stock Option Plans 2002, 2003 and 2013                
Shares                
Beginning balance (in shares)     2,800,000 2,800,000 2,800,000      
Granted (in shares)       800,000 200,000      
Released (in shares)       (1,400,000) (200,000)      
Forfeited (in shares)       (100,000) 0      
Ending balance (in shares)   2,100,000   2,100,000 2,800,000 2,800,000    
Options exercisable (in shares)   1,300,000   1,300,000        
Weighted Average Exercise Price                
Beginning balance weighted average exercise price (dollars per share) | $ / shares     $ 24.18 $ 24.18 $ 21.73      
Granted weighted average exercise price (dollars per share) | $ / shares       63.55 52.08      
Released weighted average exercise price (in dollars per share) | $ / shares       14.70 20.82      
Forfeited weighted average exercise price (dollars per share) | $ / shares       57.12 50.53      
Ending balance weighted average exercise price (dollars per share) | $ / shares   $ 42.75   42.75 $ 24.18 $ 21.73    
Options exercisable weighted average exercise price (dollars per share) | $ / shares   $ 31.11   $ 31.11        
Ending balance weighted average remaining contractual term (in years)       6 years 5 months 19 days        
Options exercisable weighted average remaining contractual term (in years)       4 years 10 months 6 days        
Ending balance aggregate intrinsic value | $   $ 53,400,000   $ 53,400,000        
Options exercisable aggregate intrinsic value | $   $ 52,000,000   $ 52,000,000